🚀 VC round data is live in beta, check it out!

Ubcare Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ubcare and similar public comparables like OptimizeRx, Sopharma Trading, Findex, Airdoc and more.

Ubcare Overview

About Ubcare

Ubcare Co Ltd is a South Korea-based company that engages in the provision of healthcare solutions. Its business divisions are: EMR solutions, distribution, pharmaceutical data, and manufacturing.


Founded

1994

HQ

South Korea

Employees

338

Financials (FY)

Revenue: $129M
EBITDA: $7M

EV

$150M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ubcare Financials

Ubcare reported last fiscal year revenue of $129M and EBITDA of $7M.

In the same fiscal year, Ubcare generated $65M in gross profit, $7M in EBITDA, and had net loss of ($1M).


Ubcare P&L

In the most recent fiscal year, Ubcare reported revenue of $129M and EBITDA of $7M.

Ubcare expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Ubcare forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$129MXXXXXXXXX
Gross ProfitXXX$65MXXXXXXXXX
Gross MarginXXX50%XXXXXXXXX
EBITDAXXX$7MXXXXXXXXX
EBITDA MarginXXX5%XXXXXXXXX
EBIT MarginXXX3%XXXXXXXXX
Net ProfitXXX($1M)XXXXXXXXX
Net MarginXXX(1%)XXXXXXXXX

Financial data powered by Morningstar, Inc.

Ubcare Stock Performance

Ubcare has current market cap of $143M, and enterprise value of $150M.

Market Cap Evolution


Ubcare's stock price is $2.82.

See Ubcare trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$150M$143M(1.3%)XXXXXXXXX$-0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ubcare Valuation Multiples

Ubcare trades at 1.2x EV/Revenue multiple, and 22.0x EV/EBITDA.

See valuation multiples for Ubcare and 15K+ public comps

Ubcare Financial Valuation Multiples

As of March 7, 2026, Ubcare has market cap of $143M and EV of $150M.

Equity research analysts estimate Ubcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Ubcare has a P/E ratio of (133.6x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$143MXXX$143MXXXXXXXXX
EV (current)$150MXXX$150MXXXXXXXXX
EV/RevenueXXX1.2xXXXXXXXXX
EV/EBITDAXXX22.0xXXXXXXXXX
EV/EBITXXX42.9xXXXXXXXXX
EV/Gross ProfitXXX2.3xXXXXXXXXX
P/EXXX(133.6x)XXXXXXXXX
EV/FCFXXX(56.2x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ubcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ubcare Margins & Growth Rates

Ubcare's revenue in the last fiscal year grew by 24%.

See operational valuation multiples for Ubcare and other 15K+ public comps

Ubcare Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX24%XXXXXXXXX
EBITDA MarginXXX5%XXXXXXXXX
EBITDA GrowthXXX25%XXXXXXXXX
S&M Expenses to RevenueXXX25%XXXXXXXXX
G&A Expenses to RevenueXXX2%XXXXXXXXX
R&D Expenses to RevenueXXX1%XXXXXXXXX
Opex to RevenueXXX48%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ubcare Public Comps

See public comps and valuation multiples for other Healthcare Software and Medical Supplies comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
OptimizeRxXXXXXXXXXXXXXXXXXX
Sopharma TradingXXXXXXXXXXXXXXXXXX
FindexXXXXXXXXXXXXXXXXXX
AirdocXXXXXXXXXXXXXXXXXX
Oneview HealthcareXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Ubcare M&A Activity

Ubcare acquired XXX companies to date.

Last acquisition by Ubcare was on XXXXXXXX, XXXXX. Ubcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Ubcare

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Ubcare Investment Activity

Ubcare invested in XXX companies to date.

Ubcare made its latest investment on XXXXXXXX, XXXXX. Ubcare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Ubcare

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ubcare

When was Ubcare founded?Ubcare was founded in 1994.
Where is Ubcare headquartered?Ubcare is headquartered in South Korea.
How many employees does Ubcare have?As of today, Ubcare has over 338 employees.
Is Ubcare publicly listed?Yes, Ubcare is a public company listed on Korea Exchange.
What is the stock symbol of Ubcare?Ubcare trades under 032620 ticker.
When did Ubcare go public?Ubcare went public in 1997.
Who are competitors of Ubcare?Ubcare main competitors are OptimizeRx, Sopharma Trading, Findex, Airdoc.
What is the current market cap of Ubcare?Ubcare's current market cap is $143M.
What is the current revenue of Ubcare?Ubcare's last fiscal year revenue is $129M.
What is the current EV/Revenue multiple of Ubcare?Current revenue multiple of Ubcare is 1.2x.
Is Ubcare profitable?No, Ubcare is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial